These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27119230)

  • 1. ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation.
    Xing Y; Ge Y; Liu C; Zhang X; Jiang J; Wei Y
    Oncotarget; 2016 Jun; 7(24):36395-36406. PubMed ID: 27119230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
    Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
    Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells.
    Ge Y; Zhou F; Chen H; Cui C; Liu D; Li Q; Yang Z; Wu G; Sun S; Gu J; Wei Y; Jiang J
    Biochem Biophys Res Commun; 2010 Jul; 397(4):711-7. PubMed ID: 20537983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
    Nami B; Donmez H; Kocak N
    Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expression.
    Gopinath S; Malla R; Alapati K; Gorantla B; Gujrati M; Dinh DH; Rao JS
    Carcinogenesis; 2013 Mar; 34(3):550-9. PubMed ID: 23222817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.
    Ikushima H; Todo T; Ino Y; Takahashi M; Saito N; Miyazawa K; Miyazono K
    J Biol Chem; 2011 Dec; 286(48):41434-41441. PubMed ID: 21987575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.
    Stoltz K; Sinyuk M; Hale JS; Wu Q; Otvos B; Walker K; Vasanji A; Rich JN; Hjelmeland AB; Lathia JD
    Neuro Oncol; 2015 Mar; 17(3):361-71. PubMed ID: 25416826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells.
    Lee SH; Nam HJ; Kang HJ; Samuels TL; Johnston N; Lim YC
    Oncol Rep; 2015 Oct; 34(4):2065-71. PubMed ID: 26239260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic trioxide regulates the apoptosis of glioma cell and glioma stem cell via down-regulation of stem cell marker Sox2.
    Sun H; Zhang S
    Biochem Biophys Res Commun; 2011 Jul; 410(3):692-7. PubMed ID: 21703238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.
    Jeon HM; Sohn YW; Oh SY; Kim SH; Beck S; Kim S; Kim H
    Cancer Res; 2011 May; 71(9):3410-21. PubMed ID: 21531766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.
    Alonso MM; Diez-Valle R; Manterola L; Rubio A; Liu D; Cortes-Santiago N; Urquiza L; Jauregi P; Lopez de Munain A; Sampron N; Aramburu A; Tejada-Solís S; Vicente C; Odero MD; Bandrés E; García-Foncillas J; Idoate MA; Lang FF; Fueyo J; Gomez-Manzano C
    PLoS One; 2011; 6(11):e26740. PubMed ID: 22069467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
    Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
    Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival.
    Pietrobono S; Morandi A; Gagliardi S; Gerlini G; Borgognoni L; Chiarugi P; Arbiser JL; Stecca B
    J Invest Dermatol; 2016 Oct; 136(10):2059-2069. PubMed ID: 27373978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
    Chou MY; Hu FW; Yu CH; Yu CC
    Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
    López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
    Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2.
    Bora-Singhal N; Mohankumar D; Saha B; Colin CM; Lee JY; Martin MW; Zheng X; Coppola D; Chellappan S
    Sci Rep; 2020 Mar; 10(1):4722. PubMed ID: 32170113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.